Business
AYURCANN REPORTS ANOTHER RECORD SALES GROWTH IN Q2 2025 OF $13,363,509
Toronto, Ontario, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF) (“Ayurcann” or the “Company”) is excited to announce record-breaking financial results for the three months ended December 31, 2024, the highlights of which are included in this news release. As a leading player in the rapidly growing cannabis industry, Ayurcann continues to demonstrate exceptional growth and operational excellence, positioning itself for long-term success. All figures are repor
About this update from Ayurcann Holdings Corp.
[{"type":"image","alt":"Ayurcann Holdings Corp.","displaySize":"","headline":null,"caption":"Ayurcann Holdings Corp.","className":"","disableSlideshowImg":false,"size":{"original":{"width":203,"height":191,"url":"https://media.zenfs.com/en/globenewswire.com/269152d55308912eddb9304883eacb65"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/WB2uH.vK1Y8HU7wcX7rNLw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTM2MDtoPTMzOTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/269152d55308912eddb9304883eacb65","width":203,"height":191}},"lazy":false},{"type":"text","content":"Toronto, Ontario, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF) (“Ayurcann” or the “Company”) is excited to announce record-breaking financial results for the three months ended December 31, 2024, the highlights of which are included in this news release. As a leading player in the rapidly growing cannabis industry, Ayurcann continues to demonstrate exceptional growth and operational excellence, positioning itself for long-term success. All figures are reported in Canadian dollars. The Company’s full set of consolidated financial statements for the three months ended December 31, 2024 and accompanying management’s discussion and analysis can be accessed by visiting the Company’s website at www.ayurcann.com and its profile page on SEDAR+ at www.sedarplus.ca.","length":805,"tagName":"p"},{"type":"text","content":"FINANCIAL HIGHTLIGHTS FOR THE THREE MONTHS ENDING DECEMBER 31, 2024","length":67,"tagName":"p"},{"type":"text","content":"Ayurcann’s Q2 2025 results reflect the strategic execution of our growth plan and solidify our position as a market leader in the Canadian cannabis space. Key highlights for the three-month period include:","length":205,"tagName":"p"},{"type":"text","content":"Revenue Growth: Ayurcann delivered a stellar $13,363,509 in gross revenue, marking another 25% increase year-over-year (compared to $10,740,248 million for the same period last year). This growth is a testament to our unwavering focus on quality, innovation, and customer demand.","length":279,"tagName":"p","attribs":{}},{"type":"text","content":"Profitability: With a 43% gross margin and an adjusted positive EBITDA1 of $815,085 in Ayurcann Inc., the Company’s wholly owned operating subsidiary, and $356,828 on a fully consolidated basis of adjusted positive EBITDA, Ayurcann continue...